Acumen Pharmaceuticals (ABOS) Debt Ratio (2023 - 2026)

Acumen Pharmaceuticals (ABOS) has 4 years of Debt Ratio data on file, last reported at 0.23 in Q1 2026.

• For the quarter ending Q1 2026, Debt Ratio rose 60.89% year-over-year to 0.23; the trailing twelve-month figure through Mar 2026 stood at 0.23 (up 60.89% YoY), and the FY2025 full-year result was 0.25, up 106.09% from the prior year.
• Debt Ratio slipped to 0.23 in Q1 2026, from 0.25 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.25 in Q4 2025 to a low of 0.1 in Q4 2023.
• A 4-year average of 0.16 and a median of 0.13 in 2024 frame the typical range for Debt Ratio.
• Across the five-year window, Debt Ratio climbed 27.69% in 2024 and soared 106.09% in 2025, its largest moves.
• Tracing ABOS's Debt Ratio over 4 years: stood at 0.1 in 2023, then grew by 27.69% to 0.12 in 2024, then jumped by 106.09% to 0.25 in 2025, then slipped by 8.42% to 0.23 in 2026.
• Business Quant data shows ABOS's Debt Ratio at 0.23 in Q1 2026, 0.25 in Q4 2025, and 0.22 in Q3 2025.